|Bid||212.50 x 1200|
|Ask||212.63 x 1200|
|Day's Range||208.04 - 213.23|
|52 Week Range||66.09 - 237.76|
|Beta (5Y Monthly)||1.31|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 08, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||215.67|
Subscribe to Yahoo Finance Plus to view Fair Value for SWAVLearn more
ShockWave Medical (SWAV) has been struggling lately, but the selling pressure may be coming to an end soon.
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don’t make them change their opinion towards a company. This time it may be different. The coronavirus pandemic destroyed the high correlations among major industries and asset classes. We are […]
Goldman Sachs (NYSE:GS) is recognizing Daniel Hawkins, CEO of Avail Medsystems, as one of the 100 Most Intriguing Entrepreneurs of 2021 at its Builders + Innovators Summit in Healdsburg, California.